CH1251125998 (XLON)
Relief Therapeutics Holding AG Aktie
2,06 CHF
Aktuelle Kurse von Relief Therapeutics Holding AG
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
London |
0QKQ.L
|
CHF
|
19.09.2024 17:12
|
2,06 CHF
| 2,17 CHF | -5,07 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -5,07 % | 83,11 % | 83,93 % | 52,59 % | -14,17 % | -98,38 % |
Firmenprofil zu Relief Therapeutics Holding AG Aktie
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action for respiratory indications, which is in Phase 3 clinical trials for treating COVID-19-induced acute respiratory distress syndrome and moderate to severe COVID-19 lung injury; in Phase 1 clinical trial for the treatment of patients with acute lung injury in other intensive care unit; and in Phase 2 clinical trial for the treatment of pulmonary sarcoidosis. The company is also developing ACER-001, a proprietary powder formulation of sodium phenylbutyrate, which has completed Phase 3 clinical trial for urea cycle disorders; and in Phase 1 clinical trial for the treatment of maple syrup urine disease. In addition, it is developing APR-TD011, a spray-formulated hypotonic acid-oxidizing solution, which is in Phase 2 clinical trial for treating epidermolysis bullosa. The company was founded in 2013 and is based in Geneva, Switzerland.
Unternehmensdaten zur Relief Therapeutics Holding AG Aktie
Name Relief Therapeutics Holding AG
Firma Relief Therapeutics Holding AG
Heimatbörse
London
ISIN CH1251125998
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Pharmaceuticals
CEO Mr. Paolo Galfetti
Marktkapitalisierung 15 Mio
Land Schweiz
Währung CHF
Mitarbeiter 0,0 T
Adresse Bâtiment F2/F3, 1202 Geneva
IPO Datum 2021-01-18
Ticker Symbole
Name | Symbol |
---|---|
London | 0QKQ.L |
Weitere Aktien
Investoren die Relief Therapeutics Holding AG halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024